Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. FUREN Group Pharmaceutical Co., Ltd.
  6. News
  7. Summary
    600781   CNE000000NM4

FUREN GROUP PHARMACEUTICAL CO., LTD.

(600781)
  Report
End-of-day quote Shanghai Stock Exchange  -  2022-09-29
2.280 CNY   -1.30%
04/29FUREN Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
04/29FUREN Group Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
2021FUREN Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
SummaryQuotesChartsNewsCalendarCompanyFinancialsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

FUREN Group Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022

04/29/2022 EDT

FUREN Group Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 349.32 million compared to CNY 494.1 million a year ago. Net loss was CNY 177.27 million compared to CNY 38.47 million a year ago. Basic loss per share from continuing operations was CNY 0.28 compared to CNY 0.06 a year ago.


© S&P Capital IQ 2022
All news about FUREN GROUP PHARMACEUTICAL CO., LTD.
04/29FUREN Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended D..
CI
04/29FUREN Group Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter End..
CI
2021FUREN Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended..
CI
2021Furen Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended J..
CI
2021Furen Group Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter End..
CI
2021Furen Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended D..
CI
2020Furen Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended..
CI
2020Furen Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended J..
CI
2020Furen Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended D..
CI
2020FUREN Group Pharmaceutical Co., Ltd. Appoints Zhu Wenliang as General Manager
CI
More news
Financials
Sales 2021 1 512 M 213 M 213 M
Net income 2021 -3 199 M -450 M -450 M
Net Debt 2021 3 974 M 559 M 559 M
P/E ratio 2021 -0,69x
Yield 2021 -
Capitalization 1 430 M 201 M 201 M
EV / Sales 2020 2,24x
EV / Sales 2021 4,10x
Nbr of Employees 2 916
Free-Float 57,2%
Chart FUREN GROUP PHARMACEUTICAL CO., LTD.
Duration : Period :
FUREN Group Pharmaceutical Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Wen Liang Zhu General Manager & Director
Xue Jiu Zhu Chief Financial Officer
Cheng Gong Zhu Chairman & Board Secretary
Wen Yu Zhu Chairman-Supervisory Board
Wei Dong Chen Independent Director
Sector and Competitors
1st jan.Capi. (M$)
FUREN GROUP PHARMACEUTICAL CO., LTD.-35.96%201
JOHNSON & JOHNSON-3.19%435 445
ELI LILLY AND COMPANY16.41%313 453
ROCHE HOLDING AG-12.23%279 092
ABBVIE INC.4.87%251 052
PFIZER, INC.-24.71%249 525